KIMIA BIOSCIENCES Financial Statement Analysis
|
||
|
The Revenues of KIMIA BIOSCIENCES have decreased by -3.39% YoY .
The Earnings Per Share (EPS) of KIMIA BIOSCIENCES has decreased by -22.66 % YoY. |
||
KIMIA BIOSCIENCES Last 5 Annual Financial Results
[BOM: 530313]
| Standalone | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹115 Cr | ₹119 Cr | ₹105 Cr | ₹129 Cr | ₹125 Cr |
| Expenses | ₹101 Cr | ₹99 Cr | ₹105 Cr | ₹134 Cr | ₹124 Cr |
| Operating Profit (Excl OI) | ₹14 Cr | ₹20 Cr | ₹-0.48 Cr | ₹-5.09 Cr | ₹0.63 Cr |
| Other Income | ₹1.62 Cr | ₹1.32 Cr | ₹1.64 Cr | ₹1.33 Cr | ₹0.93 Cr |
| Interest | ₹3.52 Cr | ₹4.56 Cr | ₹5.05 Cr | ₹4.25 Cr | ₹3.64 Cr |
| Depreciation | ₹3.91 Cr | ₹3.38 Cr | ₹3.29 Cr | ₹3.33 Cr | ₹2.94 Cr |
| Profit Before Tax | ₹8.46 Cr | ₹14 Cr | ₹-7.18 Cr | ₹-12 Cr | ₹-5.02 Cr |
| Profit After Tax | ₹7.43 Cr | ₹9.61 Cr | ₹-5.31 Cr | ₹-9.35 Cr | ₹-3.70 Cr |
| Earnings Per Share (Rs) | ₹1.57 | ₹2.03 | ₹-1.12 | ₹-1.98 | ₹-0.78 |
| PAT Margin (%) | 6.47 | 8.08 | -5.06 | -7.28 | -2.96 |
| ROE(%) | 53.70 | 186.70 | -183.25 | -91.91 | -22.22 |
| ROCE(%) | 25.24 | 42.18 | -4.18 | -14.30 | -2.32 |
| Total Debt/Equity(x) | 1.95 | 3.27 | 131.12 | 9.69 | 2.73 |
Key Financials |
||
| Market Cap | : | ₹ 158.4 Cr |
| Revenue (TTM) | : | ₹ 104.8 Cr |
| Net Profit(TTM) | : | ₹ 8.6 Cr |
| EPS (TTM) | : | ₹ 1.8 |
| P/E (TTM) | : | 18.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| KIMIA BIOSCIENCES | 11.3% | -0.2% | 7.8% |
| SUN PHARMACEUTICAL INDUSTRIES | -2% | 6% | 9.6% |
| DIVIS LABORATORIES | -4% | 22.9% | 75.8% |
| TORRENT PHARMACEUTICALS | -1.8% | 1.8% | 21.9% |
| CIPLA | -0.9% | 4.5% | -8% |
| DR REDDYS LABORATORIES | -0.4% | 13.1% | 13.7% |
| MANKIND PHARMA | -1.4% | 11.5% | 19.5% |
| LUPIN | -2% | 0.7% | 0.2% |
| ZYDUS LIFESCIENCES | -2% | 4.2% | 27% |
KIMIA BIOSCIENCES Revenues
[BOM: 530313]
| Y-o-Y | -3.39 % |
| 5 Yr CAGR | -2.07 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹115 Cr | -3.39 | |
| Mar2025 | ₹119 Cr | 13.39 | |
| Mar2024 | ₹105 Cr | -18.39 | |
| Mar2023 | ₹129 Cr | 2.89 | |
| Mar2022 | ₹125 Cr | - | |
KIMIA BIOSCIENCES Operating Profit
[BOM: 530313]
| Y-o-Y | -29.55 % |
| 5 Yr CAGR | 118.06 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹14 Cr | -29.55 | |
| Mar2025 | ₹20 Cr | Positive | |
| Mar2024 | ₹-0.48 Cr | Negative | |
| Mar2023 | ₹-5.09 Cr | Negative | |
| Mar2022 | ₹0.63 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -27.07 % |
| 5 Yr CAGR | 122.15 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 12.42% | -27.07 | |
| Mar2025 | 17.03% | Positive | |
| Mar2024 | -0.46% | Negative | |
| Mar2023 | -3.96% | Negative | |
| Mar2022 | 0.51% | - | |
KIMIA BIOSCIENCES Profit After Tax
[BOM: 530313]
| Y-o-Y | -22.66 % |
| 5 Yr CAGR | Positive |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹7.43 Cr | -22.66 | |
| Mar2025 | ₹9.61 Cr | Positive | |
| Mar2024 | ₹-5.31 Cr | Negative | |
| Mar2023 | ₹-9.35 Cr | Negative | |
| Mar2022 | ₹-3.70 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -19.93 % |
| 5 Yr CAGR | Positive |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 6.47 % | -19.93 | |
| Mar2025 | 8.08 % | Positive | |
| Mar2024 | -5.06 % | Negative | |
| Mar2023 | -7.28 % | Negative | |
| Mar2022 | -2.96 % | - | |
KIMIA BIOSCIENCES Earnings Per Share (EPS)
[BOM: 530313]
| Y-o-Y | -22.66 % |
| 5 Yr CAGR | Positive |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.57 | -22.66 | |
| Mar2025 | ₹2.03 | Positive | |
| Mar2024 | ₹-1.12 | Negative | |
| Mar2023 | ₹-1.98 | Negative | |
| Mar2022 | ₹-0.78 | - | |
KIMIA BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 530313]
| Y-o-Y | -40.16 % |
| 5 Yr CAGR | Positive |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 25.24% | -40.16 | |
| Mar2025 | 42.18% | Positive | |
| Mar2024 | -4.18% | Negative | |
| Mar2023 | -14.3% | Negative | |
| Mar2022 | -2.32% | - | |
KIMIA BIOSCIENCES Share Price vs Sensex
| Current Share Price | : | ₹33.5 |
| Current MarketCap | : | ₹ 158.4 Cr |
| Updated EOD on | : | Nov 16,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KIMIA BIOSCIENCES | 11.3% |
-0.2% |
7.8% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
KIMIA BIOSCIENCES related INDICES
You may also like the below Video Courses
FAQ about KIMIA BIOSCIENCES Financials
How the annual revenues of KIMIA BIOSCIENCES have changed ?
The Revenues of KIMIA BIOSCIENCES have decreased by -3.39% YoY .
How the Earnings per Share (EPS) of KIMIA BIOSCIENCES have changed?
The Earnings Per Share (EPS) of KIMIA BIOSCIENCES has decreased by -22.66 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs